MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$319,767K Prepaid expenses andother current assets$4,431K Restricted cash$449K Property, plant andequipment, gross$11,420K Total current assets$324,647K Operating leaseright-of-use assets$9,439K Property, plant andequipment, net$6,736K Restricted cash$2,315K Other non-currentassets$183K Accumulated depreciation$4,684K Total assets$343,320K Total liabilities andstockholders' equity$343,320K Total stockholdersequity$246,938K Total liabilities$96,382K Accumulated deficit-$711,300K Accumulated othercomprehensive loss-$192K Additional paid-in capital$958,427K Term loan, net$50,106K Total currentliabilities$26,552K Operating leaseliability, net of current...$18,172K Other non-currentliabilities$1,552K Common stock, 0.00001par value per share...$3K Accrued expenses andother current...$20,277K Accounts payable$6,275K
Balance Sheet
source: myfinsight.com

Taysha Gene Therapies, Inc. (TSHA)

Taysha Gene Therapies, Inc. (TSHA)